CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

NCT00812669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: pegfilgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
GENETIC: cytogenetic analysis
GENETIC: fluorescence in situ hybridization
GENETIC: gene expression analysis
GENETIC: mutation analysis
GENETIC: protein expression analysis
OTHER: flow cytometry
OTHER: laboratory biomarker analysis

Sponsor

Cancer Trials Ireland